AUTORISERET FYSIOTERAPEUTHOLDINGSELSKAB METTE-INVEST ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.6% 0.6% 0.6% 0.6% 0.6%  
Bankruptcy risk  7.9% 12.3% 9.0% 5.3% 5.3%  
Credit score (0-100)  32 19 26 41 41  
Credit rating  BB BB BB BBB BBB  
Credit limit (kDKK)  0.0 -0.0 -0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  -5.0 -7.0 -7.0 -7.0 -8.1  
EBITDA  -5.0 -7.0 -7.0 -7.0 -8.1  
EBIT  -5.0 -7.0 -7.0 -7.0 -8.1  
Pre-tax profit (PTP)  62.0 -126.0 3.0 159.0 204.9  
Net earnings  66.0 -120.0 5.0 166.0 207.7  
Pre-tax profit without non-rec. items  62.0 -126 3.0 159 205  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  19.0 -101 -95.0 71.0 279  
Interest-bearing liabilities  393 407 431 468 193  
Balance sheet total (assets)  451 345 342 603 539  

Net Debt  386 407 431 468 193  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -5.0 -7.0 -7.0 -7.0 -8.1  
Gross profit growth  44.4% -40.0% 0.0% 0.0% -15.2%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  451 345 342 603 539  
Balance sheet change%  39.2% -23.5% -0.9% 76.3% -10.6%  
Added value  -5.0 -7.0 -7.0 -7.0 -8.1  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -4.0 -5.0 -5.0 -5.0 -5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  18.5% -24.5% 5.4% 35.6% 42.6%  
ROI %  19.6% -26.9% 5.7% 38.1% 48.1%  
ROE %  38.5% -65.9% 1.5% 80.4% 118.8%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  4.2% -22.6% -21.7% 11.8% 51.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -7,720.0% -5,814.3% -6,157.1% -6,685.7% -2,397.1%  
Gearing %  2,068.4% -403.0% -453.7% 659.2% 69.4%  
Net interest  0 0 0 0 0  
Financing costs %  3.7% 4.0% 5.0% 5.8% 11.6%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.1 0.1 0.0 0.2 0.3  
Current Ratio  0.1 0.1 0.0 0.2 0.3  
Cash and cash equivalent  7.0 0.0 0.0 0.0 0.0  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -382.0 -399.0 -422.0 -448.0 -191.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0